The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PLRX FINANCIAL STATEMENTS

Pliant Therapeutics Inc — balance sheet, income statement and cash flow trends

PLRXPliant Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-629 K $ · -Infinity%Operating Income-97.5 M $ · -Infinity%Pre-tax Income-92.3 M $ · -Infinity%Net Income to Owners-92.3 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-629 K $—
Operating Income-97.5 M $—
EBITDA-88.1 M $—
Net Income to Owners-92.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets189.9 M
  • Equity146.9 M $77%
  • Current Liabilities16.5 M $9%
  • Long-term Liabilities26.5 M $14%

Key Figures

YoY change
Total Assets189.9 M $-36.7%
Total Liabilities43 M $-46.1%
Total Equity146.9 M $-33.2%
Cash & ST Investments158.1 M $-39.9%
Total Debt28.7 M $-52.4%
Net Debt3.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-60 M-40 M-20 M0-70.9 M $Operating41.1 M $Investing-32.1 M $Financing-61.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow-70.9 M $—
Capital Expenditures0 $-100.0%
Free Cash Flow-70.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PLRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.